Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
Files
Publication date
2018-04-05
Authors
van Son, Marieke
Peters, Max
Moerland, Rien
Noteboom, Juus L
Eppinga, Wietse S.C.
Fajardo, Raquel Dávila
Lagendijk, J J W
van der Voort van Zyp, Jochem R N
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Prostate cancer recurrences are common, even with twenty-first-century primary prostate cancer treatment modalities. The most common salvage treatment is (delayed) hormonal therapy, which is often associated with serious side-effects. Due to the risk of significant toxicity, whole-gland targeted salvage treatments remain unpopular. Consequently, developments in focal therapies have arisen. Magnetic resonance imaging (MRI)-guided focal salvage high-dose-rate brachytherapy (HDR-BT) is a novel treatment aiming for minimal toxicity in recurrent prostate cancer patients. Repeating focal treatment could, therefore, be possible in case of post-salvage recurrence. We report the case of a 77-year-old man who underwent repeat focal HDR-BT.
Keywords
prostate cancer, recurrence, brachytherapy, salvage therapy, interventional magnetic resonance imaging, Journal Article
Citation
Van Son, M J, Peters, M, Moerland, M A, Noteboom, J L, Eppinga, W S, Davila Fajardo, R, Lagendijk, J & Van der Voort van Zyp, J R 2018, 'Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer', Curēus, vol. 10, no. 4, e2429. https://doi.org/10.7759/cureus.2429